The Impact of Tofacitinib on Quality of Life in Patients with Moderate-to-Severe Psoriasis- An Observational Study

BACKGROUND: Global phase III trials have established the effectiveness and the safety profile of 5 and 10 mg twice-daily regimens of Tofacitinib for the management of psoriasis. AIMS AND OBJECTIVES: This study was aimed at assessing the improvement in quality of life in patients suffering from moder...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohta, Alpana, Nyati, Asha, Ghiya, Bhikam Chand, Mehta, Rajesh Dutt, Jain, Suresh Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389145/
https://www.ncbi.nlm.nih.gov/pubmed/37529464
http://dx.doi.org/10.4103/ijd.ijd_697_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389145/
https://www.ncbi.nlm.nih.gov/pubmed/37529464
http://dx.doi.org/10.4103/ijd.ijd_697_22

Ejemplares similares